Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
334.7 GBX | -0.39% | -1.76% | +3.40% |
01:20pm | Rotork begins buyback of up to GBP50 million in shares | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 752M 951M 79.25B | Sales 2025 * | 793M 1B 83.59B | Capitalization | 2.88B 3.64B 303B |
---|---|---|---|---|---|
Net income 2024 * | 118M 149M 12.44B | Net income 2025 * | 134M 170M 14.13B | EV / Sales 2024 * | 3.65 x |
Net cash position 2024 * | 134M 169M 14.12B | Net cash position 2025 * | 187M 236M 19.7B | EV / Sales 2025 * | 3.39 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
21.5
x | Employees | 3,342 |
Yield 2024 * |
2.27% | Yield 2025 * |
2.44% | Free-Float | 99.42% |
Latest transcript on Rotork plc
1 day | -0.45% | ||
1 week | -1.64% | ||
Current month | +3.59% | ||
1 month | +4.56% | ||
3 months | +4.69% | ||
6 months | +5.15% | ||
Current year | +3.52% |
Managers | Title | Age | Since |
---|---|---|---|
Kiet Huynh
CEO | Chief Executive Officer | 45 | 01/18/01 |
Ross Pascoe
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Paul Burke
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Janice Stipp
BRD | Director/Board Member | 64 | 01/20/01 |
Dorothy Thompson
CHM | Chairman | 63 | 01/22/01 |
Timothy Cobbold
BRD | Director/Board Member | 61 | 01/18/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 746 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 334.6 | -0.42% | 172 121 |
16/24/16 | 336 | -0.53% | 634,152 |
15/24/15 | 337.8 | +0.30% | 902,701 |
14/24/14 | 336.8 | -0.71% | 718,287 |
13/24/13 | 339.2 | -0.41% | 1,104,181 |
Delayed Quote London S.E., May 17, 2024 at 05:55 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.52% | 3.65B | |
-6.04% | 5.96B | |
-9.90% | 364M | |
+11.45% | 186M | |
-29.13% | 185M | |
-0.84% | 148M | |
+1.45% | 53.07M |
- Stock Market
- Equities
- ROR Stock